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Résumé français
Des travaux antérieurs réalisés in vitro, dans notre laboratoire, ont montré que des
neurones sérotoninergiques (5-HT) dissociés du raphé dorsal (DR) peuvent reconnaître des
signaux spécifiques de guidage axonal dans des membranes cellulaires extraites à partir de
diverses régions du cerveau néonatal, comme le cortex cérébral (Ctx), le striatum ($tr) et le
mésencéphale ventral (VM). Cette activité de guidage a été diminuée dans les membranes
traitées avec la phospholipase-C spécifique du phosphatidylinositol (PI-PLC), qui enlève
les protéines à ancrage membranaire par lien lipidique glycosylphosphatidylinositol (GPI).
Un traitement des membranes avec la protéine de fusion EphA3-Fc, qui bloque les
éphrines-A a eu un effet similaire, quoique moins grand. Les éphrines-A sont des protéines
membranaires à ancrage GPI ayant une haute affinité pour les récepteurs EphA, qui ont des
rôles reconnus dans le guidage axonal. Elles représentent ainsi des candidates appropriées
pour cette activité de guidage des axones 5-HT. Les objectifs du travail actuel étaient
d’examiner la présence d’éphrines-A dans les extraits de membrane de Ctx, de Str et de
VM néonatals de même que l’expression de récepteurs EphA dans le DR d’embryons, de
nouveau-nés et d’adultes murins. Des transferts western avec des anticorps spécifiques ont
démontré la présence des éphrines-A4 et -A5 dans les membranes extraites du Ctx, Str et
VM néonatals. D’autre part, l’hybridation in situ avec des ribosondes marquées à la
digoxygénine a montré l’expression d’EphA4, EphA5 et EphA7 dans la région du DR de
rats foetaux ou néonatals et de souris adultes. D’autres expériences, avec double marquage
de la région du DR par immunocytochimie de la 5-HT et hybridation in situ des récepteurs
EphA, seront nécessaires pour confirmer si les neurones marqués dans la région du DR
comprennent des neurones 5-HT, et si tous les neurones 5-HT sont marqués uniformément
avec les 3 sondes. L’hybridation in situ en fluorescence (fISH), avec des ribosondes
d’EphA pourrait aussi permettre dans le futur d’examiner l’expression de ces récepteurs
dans des neurones 5-HT dissociés, en culture.
Mots clés:
Neurobiologie, développement, guidage axonal, raphé dorsal, sérotonine, cortex
cérébral, striatum, mésencéphale ventral, éphrines, récepteurs Eph, hybridation in situ,
transfert western
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VRésumé anglais
Previous in vitro experiments in our laboratory have showii that serotonergic (5-HI)
neurons dissociated from the dorsal raphe (DR) region recognize specific axon guidance
signais in celiular membranes extracted from various target brain regions, i.e. neonatal
cerebral cortex (Ctx), striatum ($tr) and ventral rnidbrain (VM). This axon guidance
activity was decreased in the membranes treated with the phosphatidylinositol-specific
phospholipase-C (PI-PLC), which removes the glycosylphosphatidylinositol (GPI) anchors,
as well as in membranes tTeated with the fusion protein, EphA3-Fc, which blocks
ephrin-As. Ephrin-As, being the GPI-anchored membrane ligands ofEphA receptors,
represent proper candidates for this axon guidance activity.
The objectives of the present work were to examine the presence of ephrin-A iigands
in membrane extracts from neonatal Ctx, Str and VM, as well as the expression of EphA
receptors in the DR of embryonic, neonatal and aduit rodents. Western blot experiments
with specific antibodies showed the presence of ephrin-A4 and ephrin-A5 in membrane
extracts of Ctx, Str and VM. In situ hybridization experiments with digoxygenin-labelled
riboprobes showed a high expression of EphA4, EphA5 and EphA7 in the DR of fetai or
neonatal rat, as well as of aduit mouse.
Further experiments, with double labelling ofthe DR with 5-HT
irnmunocytochemistiy combined with in situ hybridization for EpliA receptors, will tell us
if the ceil bodies labelled in DR include 5-HT neurons, and whether ail 5-HT neurons are
uniformly labelled with the 3 riboprobes. Fluoroscent in situ hybridization (FISH) with
EphA riboprobes could also be used to determine the expression of these receptors in
dissociated 5-HT neurons in culture.
Key words:
Neurobiology, developrnent, axon guidance. dorsal raphe, serotonin fleurons, in situ
hybridization, ephrins, Eph receptors
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11. Introduction
Serotonin (5-hydroxytryptarnine or 5-HT) is an important neurotransmitter, taking
part in diverse functions during development and at maturity, in neuronal and non-neuronal
celis, including pain perception, sleep/wake cycles and neurodevelopment. Likewise, as
exemplified below, disruptions in 5-HT neuronal development or 5-HT neurotransmission
appear to be involved in mood disorders, cognitive dysfttnction, mental retardation, anxiety
and aggression.
Therefore, a better knowledge ofthe molecules involved in the development ofthe
5-HT neurons is currently needed. There has been some progress, recently, in the
identification of factors influencing the differentiation of 5-HT neurons (see below), but
littie is currently known about the molecuies that guide 5-HT axons to their multiple
innervation targets (SharifAskari, 2006).
Recent work in our laboratory show that 5-HT neurons ofthe dorsal raphe (DR) can
recognize axon guidance signals in membrane purified from different brain regions, i.e.,
cerebral cortex (Ctx), striatum (Str) and ventral midbrain (VM) (Petit et al., 2005; Sharif
Askari, 2006). Some ofthese signais were sensitive to prior treatment ofthe membranes
with phosphatidylinositol-specific phospholipase-C (PI-PLC), removing GPI-anchored
membrane proteins. Arnong those signals, some were inducing the branching of 5-HT
axons. This latter effect of the membranes was inhibited by a prior treatment with a fusion
protein comprising the extracellular dornain of the EphA3 receptor and the fc domain of
human immunoglobulin (EphA3-Fc); an agent interfering with the binding of ephrin-As
with EphA receptors. Thus, these resuits suggest a role for the ephrin-A and EphA guidance
molecules in the branching of 5-HT axons.
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The present work was undertaken to further test this hypothesis, by examining the
presence of ephrin-A molecules at the level of 5-HT innervation targets (Ctx, Str and VM),
as well as the expression of EphA receptors by 5-HT neurons ofthe DR.
In the following paragraphs, we will first review briefly the basic current knowledge
on 5-HT neuronal systems, their roles in some neurological diseases, and the molecules
involved in their development.
1.1 Serotonin metabolism and neurotransmission
1.].] Biosynthesis of5-HT
In 1930, Erspamer and colleagues identified a molecule from enterochromaffin celis
in the gastrointestinal tract that they named “enteramine”. In 194$, Page and colleagues
isolated a vasoconstrictor substance in blood serum that they named serotonin (Lozeva
Thomas, 2004; Pucadyil et aÏ., 2005).
Only about 1-2% of total body 5-HT is present in the central nervous system (CN$).
Serotonin itself cannot pass the blood brain barrier, and must be synthesized locally. In the
CNS, it is synthesized by 5-HT neurons, from the precursor amino acid L-tryptophan,
through two enzymatic steps. The first step is hydroxylation of tryptophan that takes place
in the neuronal cytosol, catalyzed by the enzyme tryptophan hydroxylase. It is the rate
limiting step in 5-HT synthesis and produces 5-hydroxytryptophan. The second step is
catalyzed by aromatic L-amino acid decarboxylase, which decarboxylates
5-hydroxytryptophane to 5-HT. Tryptophan is present in blood at high concentrations
depending on dietary supply. The availability oftryptophan in the CNS depends on the
balance between cerebral demand and the rate oftryptophan active transport through the
blood brain barrier. for this specific transport, tryptophan has to compete with other neutral
3amino acids, like phenylalanine, leucine and methionine (Russo et al., 2003). In normal
conditions, tryptophan hydroxylase is flot completely saturated by tryptophan, so any
change in the transport ofthis aminoacid across the blood-brain barrier may affect the
synthesis rate of 5-HT and 5-HT-dependant behaviors or functions (Frazer & Hensler,
1994).
1.1.2 $erotonin storage and release
Like other neurotransmitters, 5-HT is primarily stored in storage vesicles. It is
accumulated into the vesicles by the vesicular monoamine transporters (VMAT- 1, present
in endocrine and paracrine ceils in peripheral organs, or VMAT-2, the predorninant forrn in
CNS). VMAT-2 may transport 5-HT, dopamine, adrenaline, noradrenaline or histamine. It
uses the proton gradient that is present across the vesicular membrane, as the motive force.
The release of 5-HT into the synaptic clefi depends on the firing rate of 5-HT
neurons, but is also regulated by somatodendritic and terminal autoreceptors (Squire LR,
2003).
Other molecules may also regulate 5-HT release, such as Inhibitory Protein Factor,
or IPF, which has been shown to inhibit the vesicular uptake of 5-HT - or other
neurotransmitters -, and thereby influence the size of its quantal release (Tamura et al.,
2001).
1.1.3 Inactivation ofreÏeased 5-HT
Serotonin neurotransmission also depends on its reuptake from the synaptic clefi.
Eighty percent of released 5-1-IT is inactivated by reuptake (active membrane transport) and
recycling. The 5-HT transporter (SERT) belongs to a family ofNa7CF-dependent
4transporters with 12 transmembrane domains (Iversen, 2006). Inside the nerve terminal,
5-HT is catabolized by mitochondrial monoamine oxidase (MAO) into 5-hydroxyindole
acetaldehyde, and then oxidized to 5-hydroxyindoleacetic acid, the main metabolite of
5-HT in CNS (Cooper JR, 1996). Monoamine oxidase exists in two forms, MAO-A and
MAO-B, that have different distributions, substrate selectivities and structures (Saura et al.,
1992). Monoarnine oxidase-A preferentially oxidizes 5-HT and norepinephrine, whereas
MAO-B preferentially oxidizes phenyl ethylamine (see Nishi et al., 2006). Interestingly, it
is MAO-B, which has a lower affinity for 5-HT, which is expressed in 5-HT neurons (and
glia).
1.1.4 $erotonin receptors
There are at least 14 different 5-HT receptors, classified into 7 major types, named
5-HT1 to 5-HT7 with subtypes for 5-HT1 (5-HTJA, 5-HTIB, 5-HT1D, 5-HTIE, 5-HTIF),
5-HT2 (5-HT2A, 5-HT23, 5-HT2c), and 5-HT5 (5-HT5A, 5-HT53) receptors. With the
exception of 5-HT3, which is an ionic channel receptor, the others are G-protein-coupled
receptors with 7 transmembrane-spanning domains. The 5-HT1 subtypes and 5-HT4 activate
or inhibit adenylate cyclase, whereas 5-HT1c and 5-HT2 stimulate the phospholipase-C
(PLC) pathway that increases the intracellular levels ofdiacylglycerol and inositol 1,4,5-
triphosphate (Oh et al., 2001).
Among the 5-HT receptors, 5-HT1A has been the rnost extensively studied. It has
been stably expressed into several neuronal and non-neuronal celi lines, and it is the earliest
receptor appearing during development, with its highest peak during the prenatal period
(Whitaker-Azmitia, 2005). It is encoded by a gene lacking introns. It is thought to have an
active role during neural development and a neuroprotective activity against apoptosis and
degeneration. It has its highest expression in hippocampus, raphe nuclei, amygdala,
5hypothalamus, and cortex and its lowest expression in the basal ganglia, substantia nigra
and cerebellum. This pattem of expression is consistent with 5-HT roles in
thermoregulation, aggressive and sexual behaviour, mood, appetite and sleep-wake cycle.
At the sub-cellular level, 5-HT1A is located in the somato-dendritic region ofraphe fleurons,
where it acts as an autoreceptor inhibiting 5-HT celi firing tbrough inhibition of cAMP. In
hippocampus, it is found on postsynaptic fleurons, acting as a heteroreceptor. Because of
the various known functions of 5-HT lA. this receptor has been considered as a
pharmacological target for several disorders, notably neuro-developmental impairments
such as autism ($tamford et ai., 2000; Pucadyil et al., 2005).
The 5-HT2 family subtypes, 5-HT2A, 5-HT2B and 5-HT2, are similar in structure,
pharmacology and signal transduction pathway. The genes of 5-HT2A and 5-HT2B receptors
have 2 introns, whereas there are 3 for 5-HT2. Ail 3 bind to phospholipase-C and mobilize
intracellular calcium. Antagonists of 5-HT2 have been considered as potential treatment for
schizophrenia, anxiety, sleep disorders and migraine. Receptor 5-HT3 is a ligand-gated ion
channel. It is highly expressed in the dorsal vagus complex, in brainstem, a center initiating
and coordinating the vomiting reflex; and thus, 5-HT3 antagonists are used as antiemetic
medication. Its overali expression is low in the forebrain. The 5-HT4 receptor, modulates
dopamine and acetylcholine release in CNS, and its activation increases cognitive
performance, with also some adverse reactions, like anxiety (Bames & $harp, 1999).
Receptors 5-HT5, 5-HT6, and 5-HT7 were discovered and cloned about ten years
ago. but there is stiil littie known about their functions or signaling pathways. There is
some evidence that 5-HT6 might be involved in appetite, cognition, leaming. psychosis, or
convulsions (Glennon, 2003).
61.2 Serotonin impairments in neurological or psychiatric diseases
Serotonin, being an ubiquitous neurotransmitter in the CNS, has naturally been
involved in various neurological and psychiatric disorders. We will briefly discuss the
current state of knowledge for a few of these disorders.
1.2.1 Migraine
Migraine is a chronic neurological disorder manifesting as attacks of severe
unilateral and pulsatile headaches associated with nausea, photophobia and increased
reactivity to sensory stimuli. The crisis is aggravated by physical activity, and may be
accompanied by an aura. It has a one year prevalence of 13% and is more prevalent in
women (Linde, 2006).
In migraine subjects, the plasma levels of 5-HT are lower, and those of
5-hydroxyindoleacetic acid (5-HIAA) higher than in normal individuals between aftacks,
whereas the reverse occurs during migraine attacks. It thus seems that blood 5-HT
metabolism increases in migraine subjects during headache-free periods, but decreases
during attacks (ferrari et al., 1989).
Tryptophan depletion in migraine patients increases headache and nausea episodes
in comparison with normal individuals (Drummond, 2006). Receptors 5-HTIB and 5-HT1D
play important roles in migraine modulation, via mechanisms known to mediate vascular
smooth muscle constriction and to inhibit vasoactive peptide synthesis. Treatment with
5-HT1B,1D receptor agonists, like sumatriptan and zolmitriptan, decreases the attack rates in
migraine headache subjects. Serotonin can also produce dilatation of intra and extra cranial
vessels via 5-HT7 receptors. The mRNA of 5-HT7 is highly expressed in cranial vessels and
5-HT7 activation may induce excitatory activity in the nervous system and cause
7hyperalgesia and neurogenic inflammation. Most ofthe 5-HT receptor antagonists used in
prophylaxis of migraine have a high affinity for 5-HT7 receptors. Reduction ofthis receptor
can also decrease the rates of migraine attacks in susceptible individuals (Terron, 2002).
1.2.2 Serotonin in sleep disorders
For the first time, in 195$, Bradley found out that injection of 5-HT in the lateral
ventricles of a cat, induced a short period of arousal foïÏowed by drowsiness and sleep.
Jouvet, in 1967, found that lesions of the raphe nuclei region induced a lack of sleep, while
the size of the lesions correlated positively with sleep loss and negatively with remaining
brain 5-HT (Portas et aÏ., 2000).
$erotonin is viewed as a sleep and a wake neurotransmitter. The levels of extra
cellular 5-HT, and the discharge rates of 5-HT neurons in DR increase during waking
periods, and decrease progressively during slow wave sleep ($WS) to reach a minimum
level during paradoxical sleep, or rapid eye movernent (REM) sleep. During SWS, the
decrease in 5-HT levels is mediated by an activation of inhibitory GABA in the DR region.
In REM phase, histamine and phenylephrine antagonists reverse the inhibition of 5-HT
neurons, but GABA antagonists are without effect during this phase (Adeil et al., 2002).
Different mechanisms take part in the activation or inhibition of 5-HT neurons
during the sleep/wake cycle (Portas et al., 2000). The inhibitory effect of cholinergic
neurons is mediated via 5-HT1A receptors on 5-HT neurons ofthe DR, during the REM
phase. Local activation of 5-HT lA in DR region augments REM sleep in both rats and cats.
Agonists of 5-HT18, dose-dependently increase the waking periods and reduce REM sleep,
without effect on the SWS phase. Receptors 5-HT18 are located on cholinergic,
glutamatergic and GABAergic axonal terminais. Serotonin also acts on 5-HT2A and 5-HT2
$receptors located on thalamic reticular nucleus neurons, inducing arousal. The 5-HT2
receptor is also involved in the regulation of SW$ and respiratory control during sleep.
Serotonin has a facilitatory effect on SW$, via 5HT2B receptors, and an inhibitory effect
rnediated by 5-HT2A. Agonists of 5-1112 also increase sleep apnea attacks during SWS.
(Popa et al., 2005)
Narcolepsy, a well-recognized type of hypersomnia, starts with excessive daytirne
sleepiness that can lead to cataplexy in a few years. Cataplexy is defined as a skeletal
muscle atonia, usually triggered by emotional stimuli, that usually lasts about 2 min. The
inhibitory pathways of descending motor neurons are excessively activated during
cataplexy attacks (Young & Suber, 2006). PET scan experirnent using a S-HTI1A
radioligand in narcoleptic patients showed that the binding potential ofthis receptor was
increased significantly during sleep versus wakeftilness, in whole brain and, specifically, in
temporal, mesial temporal, and cingulate cortex. This finding demonstrates that there is
increased availability of 5-HTIIA receptor in the sleep phase in narcoleptic humans. (Derry
et al., 2006).
Sleepwalking (somnambulism) is a special type ofparasomnia characterized by
several motor behaviours, including walldng, running and aggressive behaviours that start
during stages 3- 4 of SWS. Sleepwalking is more common in chiidren, and could thus be
assurned to be a development disorder. During sleepwalking periods, the firing rate of 5-HT
neurons increases and, interestingly, paroxetine (a SSRI), which increases SWS, can also
induce sleepwalking episodes. febrile illness can be a precipitating factor for
somnambulism. During fever, the total brain concentration of 5-HT increases, and could be
the trigger for sleepwalking episodes (Juszczak & Swiergiel, 2005).
91.2.3 Depression
Major depressive disorder is an important clinical problem with lifetime risk of 15-
20% ofthe general population. The prevalence is twice in women than in men and is
associated with a high risk of suicidai behaviour (15%) (Albert & Lemonde, 2004).
Symptoms include depressed mood or reduced interest, non reactive mood, helplessness,
somatic and psychic anxiety, hopelessness, change in sleep and appetite (decrease or
increase), impaired concentration and overexpression of anger.
The relationship between 5-HT and depression was realized for the first time in
1975 when reserpine, a monoamine depleting agent (used to decrease blood pressure)
induced depressive symptoms in susceptible patients. Altered 5-HIAA concentration in the
C$F ofdepressed cases and suicide victims supported the 5-HT hypothesis. Tryptophane
free diet is also known to induce a relapse of depressive symptoms in patients that have
been treated with an SSRI.
Detection of susceptible genes for affective disorders, like major depression, is
complicated by the multiple phenotypes, smail effect of individual genes and interaction
between environmentai and genetic factors. Genetic poiymorphism of 5-HT-associated
molecules, like SERT or MAO, are considered as candidates in affective disorders,
including major depressive disorders (Cryan & Leonard, 2000).
The 5-HT1A receptor has been implicated also in the pathology of major depression.
Positron-emitting tomographic (PET) imaging using a 5-HT1A radioligand showed that this
receptor’ s binding potential is reduced in depression, particularly in midbrain raphe
(Drevets et al., 1999).
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The hypothalamic-pituitary-adrenal axis is dysregulated in a large proportion of
depressed patients, leading to increased secretion of cortisol. This hypercortisolemia may
contribute to aetiology of depressive symptoms. Chronic administration of corticosterone in
rats induced reduction in sensitivity of 5-HTIA in DR, whereas such effect was flot reported
in rats with acute administration corticosteroids (Fairchild et al., 2003).
Serotonin dysfunction is also implicated in suicidai behaviour, in depressed cases. A
decrease in 5-HT lA signal transduction (coupling with adenylate cyclase) was reported in
suicide victims (Hsiung et al., 2003).
Sorne transcription factors might potentially be involved in altering the levels of
brain 5-HT1A. For example, Freud-l is a transcription factor with a helix-loop-helix DNA
binding domain, a calcium-dependent binding domain, a PKC conserved region and a
phospholipid binding domain. Its rnRNA and protein have been detected in the raphe
nuclei, cerebral cortex, hippocampus, and hypothalamus and they co-localize with 5-HuA.
An intact calcium binding domain is necessary for the function of Freud-1. Alteration in the
level of Freud-1 expression, or activation of Freud-1 by decreased levels of intracellular
calcium, down regulates the expression of 5-HTIA receptors. Thus, altered expression of
such factors might be implicated in depressive disorders, even if the 5-HT1A gene itself is
not affected (Albert & Lemonde, 2004).
Sleep deprivation is an effective treatment for mood swings in depressive patients.
There are several mechanisms underlying the effects of sleep deprivation on depressed
cases. In rat, sleep deprivation causes a down regulation ofnorepinephrine and 5-HT
transporters, and increases the availability of NE and 5-HT in the synaptic space. This
effect is the same that has been observed during intake of certain antidepressants in several
brain regions (Hipolide et aÏ., 2005). Also consistent with an antidepressant effect of sleep
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deprivation is that sleep deprivation also increases 5-HT levels in hippocampus (a region
higffly implicated in the pathophysiology of depression) in rat models (Lopez-Rodriguez et
aÏ., 2003). Afler 24 hours of sleep deprivation, the highest 5-HT increase, in comparison
with normal controls, was observed in the hypothalamus, in une with the known role of this
area in regulating sleep/wake cycles and with the participation of 5-HT in this function
(Senthilvelan et al., 2006).
1.2.4 $chizophrenia
Schizophrenia (SCZ) is a catastrophic disease with a prevalence of 0.5 to 1.0
percent of the population. The profound and pervasive cognitive and emotional
djsturbances that characterize SCZ suggest a serious underlying brain disease affecting
multiple functions and systems. Clinical symptoms of SCZ are divided in two categories:
positive symptoms like delusion, hallucination, disorganized speech and bizarre behaviour,
and negative symptoms such as anhedonia, poverty of speech, flat affect, social withdrawal
and psychomotor retardation. The etiology ofthe disorder is complex. Genetic, early
environmental risk factors (matemal infection, obstetric complications, later spring/winter
birth) and late environmental factors (immigration status, chronic cannabis use, stress),
uniquely or in combination, are believed to give rise to the disorder (Winograd-Gurvich et
al., 2006).
Several genes have been potentially associated with SCZ, including neuregulin-1
dysbendin-1, and Disrupted-in-Schizophrenia-1 (DISC-1) (Ishizuka et al., 2006; Ross et al.,
2006).
The classical hypothesis for SCZ is the dopamine hypothesis, implicating a
hyperactivity of dopamine receptors (D2) in the mesencephalic projections to the limbic
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striatum. Nevertheless, a 5-HT hypothesis of SCZ has emerged, when it was found that
LSD (d-lysergic acid diethylamide) had a strong inhibitory effect on 5-HT neurons ofthe
DR, and that the clinical presentation of LSD-like hallucinations was very similar to SCZ.
There is a potent correlation between the affinity ofhallucinogenic drugs for 5-HT2A
receptors and the level of hallucination in human subjects. Hallucinogens increase ifie rate
of glutamate release in the neocortex, via activation of 5-HT2A receptors. Glutamate release
activates NMDA-type receptors and induces excitatory activity in cerebral cortical neurons,
a pattem similar to that observed in the hallucinating phase of $CZ (Aghajanian & Marek,
2000). Moreover, the amounts of 5-HT1A and 5-HT2A are altered in SCZ (respectively
increased and decreased) and certain polymorphisms for 5-HT2A gene have been associated
with SCZ (Miyamoto et al., 2003).
Positron-emitting tomographic studies, in at risk individuals, showed decreased
expression of 5-HT2A in prefrontal cortex. This pattem of alteration was also observed in
psycho-affective disorders, indicating that, perhaps, these two categories share common
5-HT impairments in prefrontal cortex (Hurlemann et al., 2005). The typical antipsychotics
that block D2 receptors only decrease the positive symptoms of SCZ, whereas atypical
antipsychotics, like Clozapine whose effect is mediated by 5-HT2A, is a potent medication
for the control of negative symptoms. It thus seems that there is a correlation between
5-HT2A receptors and negative symptoms in SCZ (Akhondzadeh, 2001; Sawa & Snyder,
2002).
Post-mortem studies showed altered levels of other 5-HT receptors in the cerebral
cortex of subjects with SCZ, but it is not always clear that this alteration resuits from the
antipsychotic medication, or participates in the pathophysiology of SCZ. A recent study
showed a significant decrease in the binding capacity of a radioligand, SB269970, specific
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for 5-HT7, in Brodmann’s area 9 of SCZ patients that were neyer treated with such
medication. The same study reported no significant differences in the binding of
surnatryptan, which specifically binds both 5-HT1 D and 5-HT1 F. It was thus concluded that
5-HT7 rnight be involved in pathophysiology of $CZ (Dean et al., 2006).
1.2.5 Down Syndrome
Down syndrome is a common chromosomal anomaly, with a prevalence of 1 in $00
live births. li resuhs from the trisomy of chromosome 21, and is the most common genetic
cause of mental retardation. The risk of having an affected child increases with maternai
age. The affected chiidren show earÏy mental retardation and aberrant behavior, as weli as
cognitive dysfunction with Alzheimer’s disease-type neurodegeneration in early adulthood.
Down syndrome is accompanied with lower levels of 5-HT in blood, CSf and brain
(post-rnortem). The gene coding for 5-HTIA is located on chromosome 21. In normal
fetuses, the levels of 5-HTAI reach a peak in hippocampus and cerebral cortex, at
approximately 24 weeks of gestation. In affected fetuses, the levels of 5-HT1A are below
those of the normal individuals at 24 weeks of gestation and remain low in the brain of
neonates (Okado et al., 2001; Stasko et al., 2006).
In affected aduits, there are region-specific anomalies in 5-HT innervation.
Serotonin levels are decreased in caudate nucleus and temporal cortex, whereas higher
amounts were reported in occipital and frontal cortex (Seidi et al., 1999; Whitaker-Azmitia,
2001). The level of SERT is also significantly increased in prefrontal cortex, but flot in
cerebellum (Gulesserian et al., 2000).
Si 0013 is an astroglial-derived, calcium-binding protein that was shown to have
trophic effects on 5-HT neurons. The gene coding for $10013 is also located on
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chromosome 21, and the levels of this protein are elevated in the biood and brain of Down
syndrome cases. Transgenic mice over-expressing Si 003 show some morphological
changes similar to Down syndrome cases, like overdeveiopment and eariy loss of dendrites
in the hippocampus. In behaviourai experiments, these animais show ieaming and mernory
deficits and exhibit more approaches to novel and harmfui objects in comparison with
normai mice. Recentiy, the amniotic leveis of $1 003 have been proposed for prenatal
diagnosing of Down syndrome (Whitaker-Azmitia, 2001; Beil et aÏ., 2003).
The brain in Down syndrome is characterized by decreased numbers of cortical
neurons, deformed dendritic trees and spines, defects in cortical larnination and abnormal
synapses. In normal individuais, spine density and size of pyramidal dendritic trees increase
with postnatal development, reach to peak at around 1 year, and then decrease to reach the
aduit value. Synaptogenesis follows a similar pattem in cerebral cortex. In Down syndrome
patients, the overproduction of spines does not happen and spine density decreases
graduaily in the postnatal period. Because of this neuro-deveiopmentai defect, brain size in
Down syndrome is normal at embryonic ages, and near normal in neonates, but decreases
during, as well as afler the first year of life (Okado et al., 2001; Nelson et al., 2006).
1.2.6 Autisrn
Autism is a neuro-developmental disorder with a prevalence of 1-2 per 1000 with a
large range of severity. There are more than 15 candidate genes associated with autism.
However, environmental factors are also important, as concordance of disease in
monozygotic twins is less than 100%, and the phenotypic expression of the disease differs
widely, even between monozygotic twins (Santangeio & Tsatsanis, 2005).
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Autism is characterized by a triad of behavioral defects in social skills, language
development and stereotyped behaviour. Cognitive deficits, affective flatness, lack of
interest and perseveration are usually present (Boylan et aÏ., 2006).
Early findings ofhyperserotoninemia have been reported in 30% of autistic patients.
On the other hand, trytophan depletion in patients can increase stereotyped autistic
behaviour, although measurement of 5-HIAA in cerebrospinal fluid (CSf) showed no
difference between autistics and normal subjects. functional neuro-imaging studies showed
irnpaired regional 5-HT synthesis in the cerebral cortex of autistics, compared with normal
subjects. Positron-ernitting tomographic studies in boys with autism showed unilateral
decreases in 5-HT synthesis in the frontal cortex and thalamus, and augmented levels in
contralateral dentate nucleus of cerebellum. These 3 regions are anatomically connected via
the dentato-thalamo-cortical pathway (taking part in sensory integration and speech skills)
that is apparently impaired in autistic patients. These regional anomalies in 5-HT synthesis
could explain why total 5-HIAA concentrations in CSF are flot different between normal
subjects and autistic cases. Altogether, the evidence supports that impairment in 5-HT
systems could participate in autistic behaviour and phenotype (Scott & Deneris, 2005; Lam
et al., 2006).
There are both environmental and genetic hypotheses for autism. There is a higher
prevalence of autistic disorders in chiidren that have been exposed to intrauterine drugs that
increase 5-HT levels, like cocaine and possibly alcohol (Lam et al., 2006). It has also been
reported that plasma 5-HT levels in mothers of autistic chiidren are significantly lower than
those ofmothers of normal newboms. Thus, low maternai plasma 5-HT, during fetal
deveiopment ofthe CN$, can itseifbe a risk factor for autism (Connors et al., 2006).
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One of the most likely candidate genes for autism is the SERT gene (locus
SLC6A4). The 5-HT transporter is a transmembrane protein with a high affinity for 5-HT.
A polymorphism has been reported for the promoter ofthis gene: a short allele (with a
frequency of 43%) and a long allele (with a frequency of 57%). The short allele was
associated with severely autistic patients, while the long allele was associated with
rnild/moderate cases (Tordjrnan et al., 2001). Specific 5-HT reuptake inhibitors (SSRI),
which block SERT, reduce the hyperactive, compulsive and stereotyped behaviours in
autism. Risperidone, an antipsychotic that blocks dopamine and 5-HT post-synaptically
also reduces anxiety, aggression and self-injury behaviours in autistic patients.
Another candidate gene is ReeÏin, coding for a protein, that acts as an extracellular
matrix protein responsible for correct lamination of the cerebral cortex during the
embiyonic period and involved in ceil signaling and synaptic plasticity in the adult life
(Fatemi, 2002). Post-rnortem studies showed that Reelin signaling is impaired in frontal
cortical and cerebellar areas of autistic brains in comparison with control subj ects (Fatemi
et al., 2005). The anatomical defects in Reelin knockout mouse resemble those reported in
individuals with autisrn (such as cerebellar hypoplasia and decrease in number of Purkinje
cells).
Engrailed is still another candidate gene. It is a transcription factor taking part in the
development of the midbrain and cerebellum, during the embryonic and early postnatal
period. Engrailed genes (1, 2) control the development of 5-HT neurons in the DR and
noradrenergic neurons in locus coeruleus. In Engrailed double knockout mice, the
population of 5-HT and noradrenergic neurons of midbrainlhindbrain are highly reduced.
Mutations of Engrailed produces a cerebellar phenotype similar to that described in autism
(Bartlett et al., 2005; Simon et aÏ., 2005).
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Brain imaging studies in affected children showed that they have smaller than
normal brain size at birth, but that the brain grows faster in the first years of life, resulting
in increased cortical volumes. This abnorrnal growth then slows down, so in late
adolescence the autistic brain has the sarne size as the normal. Magnetic resonance
imaging, in newboms autistics showed increases in cerebral cortical gray matter, as well as
cerebrai and cerebeilar white matter (Boylan et al., 2006). In SERT knockout mice, the
excessive levels of 5-HT induce aiterations in arborisation and segregation of
thalamocortical terminais. In this mode!, a reduction in 5-HT clearance, and an over
stimulation of 5-HTIB receptor were reported as potentially responsibie for a decrease in
thickness of cortical layer IV. The SERT mutant animals also showed some other
neuroanatomical abnormalities reminiscent of those found in autistic brains, like increased
neuronal packing densities in hippocampus, amygdaia and entorhinal cortex, and
augmented numbers ofneurons in cerebrai cortex. The association between increased
cortical gray matter and reduction in SERT also supports the role for extracellular 5-HT in
stirnulating abnormal brain growth and macrocephaly in autistic patients (Altamura et al.,
2006).
1.3 Roles of 5-HT in development
Evidence from biochemical, pharmacologicai and ciinical studies indicate a roTe for
the 5-HT systems in CNS development. A direct involvement of 5-HT has been disclosed
in the development ofthe architecture ofthe somatosensory cortex. Indeed, 5-HT depletion
in newbom rat caused a significant reduction in the size of vibrissae-related barrels of
thalamocortical afferents. But this reduction was not associated with a reduction of the
brain or cortical size, or a decrease in somatosensory cortex dimensions (Benneft-Clarke et
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al., 1994; Gu, 2002). These changes are reminiscent of defects described in the autistic
brain (Bauman & Kemper, 2005).
Reelin is among the genes potentially associated with autism (see above). Now,
5-HT axons innervate the marginal zone during the prenatal period and make synaptic
contacts with the soma and proximal dendrites of reelin-producing Cajal-Retzius celis, as
eariy as E17 (Janusonis et al., 2004). Blockade ofthe 5-HT input, using
5-methoxytryptamine, a 5-HT1 and 5-HT2 receptor antagonist, led to altered reelin levels in
the brain ofnewborn pups and resulted in a disruption ofthe laminar and columnar
organization of the cerebral cortex, also similar to defects described in autistic cerebral
cortex (Bauman & Kemper, 2005).
An excess of 5-HT (in knock-out MAO-A mice) also causes abnormal branching of
thalamocortical axons in layer IV ofthe somatosensory cortex. hi double TrkB and MAO-
A knock-out mice, there was an even more severe phenotype than in either mutant animais
(a widespread tangential and radial expansion ofthalamocortical axons). These
observations indicate that 5-HT and TrkB signalings may act together to cluster
thalarnocortical axons in layer IV (Vitalis et al., 2002).
Chronic tryptophan restriction in rat was reported to have adverse effects on the
density of dendritic spines in pyramidal neurons of hippocampal CAl region, and on the
dendritic arborization and number of dendritic spines of pyramidal neurons in the third
layer of prefrontal cortex. These changes correlated with defects in short term mernory
(Feria-Velasco et al., 2002). Serotonin depletion by para-chloroamphetarnine (pCA), in P14
rats, also induced reductions in the number and length of dendritic spines of dentate gyms
granule ceils, suggesting that 5-HT has a neurotrophic action on these neurons (Yan et al.,
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1997; Faber & Haring, 1999). This neurotrophic action of 5-HT was apparently mediated
by 5-HTJA receptors, since subcutaneous injection ofthe 5-HTIA antagonist, NAN-190,
also resulted in permanent loss of dendritic spines. This resuit shows that the first two
weeks of life constitute a critical period for the action of 5-HT on developing granule ceils.
In the cerebellum, 5-HT axons and receptors appear early after birth, and influence
dendrite formation on Purkinje celis. In vitro studies on cerebellar suces suggested that the
dendritic growth ofPurkinje ceils was promoted by a 5-HTIA receptor agonist and inhibited
by a 5-HT2A receptor agonist (Kondoh et al., 2004).
1.4 Organization of the 5-HT systems
Studies on the development of 5-HT neurons showed that they develop early in fetal
life, in two separate clusters in brainstem: a rostral one, just caudal to the mesencephalic
flexure, that gives rise to almost ai! ascending 5-HT fibers, and a caudal cluster in the
medulla oblongata that gives rise to the majority of descending fibers. The 5-HT neurons in
brainstem have been classified into 9 groups, Bl-B9. Tlie Bi, 32/4 and 33 groups
constitute the caudal cluster, whereas the B5/$, B6/7 and B9 groups form the rostral cluster.
Group Bi is located in nucleus raphe pallidus, which is the most ventrally placed 5-HT
neuron group, in the medulla oblongata. Groups 32 to B4 are in nuciei raphe obscurus and
raphe magnus and in the periventricular gray of medulla oblongata. Groups B5 to B$ are
located in the midbrainlpontine medial raphe and dorsal raphe nuclei, and B9 is a lateral
extension ofB$, in the media! lemniscus (see Harding et al., 2004; Cordes, 2005).
From the brainstem, 5-HT neurons have extensive projections to virtually ail areas
of brain and spinal cord. The present work concems the ascending projections of the DR,
notably those that innervate the cerebral cortex, the striatum and the ventral midbrain.
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These axons initially enter the medial forebrain bundie and then divide into several
pathways to innervate their target structures, including the olfactory bulbs, hypothalamus,
thalamus, septal area, striatum, hippocampus and cerebral cortex. The basal ganglia receive
dense 5-HT projections from the B7 group, more concentrated in the posteromedial
striatum and globus pallidus. The same 5-HT neurons also send collaterals to the ventral
midbrain. Most cytoarchitectural areas of cortex receive their 5-HT innervations from B7
and B9, which innervate the entire cerebral cortex, with particular subdivisions ofneurons
innervating specific cortical or subcortical regions. For example, 5-HT neurons in the
lateral wing of DR innervate the primary visual cortex, as well as the superior colliculus or
lateral geniculate thalamic nucleus. In contrast, group B9 innervates the outer cortical
layers of most cortical regions (Harding et aÏ., 2004).
1.5 Molecules influencing the differentiation of 5-HT neurons
1.5.1 $onic hedgehog and Fibroblast Growth factors
The differentiation of 5-HT - and dopamine - neurons is controlled by several
signals expressed by dorso-ventral or antero-posterior compartments. Sonic hedgehog (Shh)
is a signalling protein that is expressed by the notochord and floor plate, as well as
prechordal mesoderrn, and has a major role in the dorso-ventral patteming of the neural
tube, early in the development of the CNS (Cordes, 2005). In vitro experiments, using
explants of the midbrainlbindbrain, or of more caudal hindbrain have shown that the
expression and signalling of both $hh and FGF$ are necessary for the differentiation of the
rostral 5-HT cdl groups, whereas, differentiation of the caudal groups, which are farther
from the brainstem isthmus, the source of FGF$, only depends on Shh. FGF2 and FGF4
were also shown to induce the differentiation of 5-HT neurons in more rostral, midbrain
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explants, perhaps to the expense of dopamine neurons, suggesting that FGF4 in midbrain
may change the fate of neuronal progenitors to become 5-HT fleurons. These findings
suggest that these 3 signals act in concert to produce rostral 5-HT neurons (Ye et al., 199$).
1.5.2 Gli transcrztionfactors in the djfferentiation of5-HT neurons
One of the downstream components of the $hh signailing pathway, during
embryogenesis, is the Gli transcription factor famiiy. Gli 1, -2 and -3 are the major members
ofthis group that are expressed throughout the neural plate prior to floor plate induction
(although G1i3 is weak or absent from the midline). In G1i2 knockout mice, the floor plate
does flot form in the midbrain, hindbrain and spinal cord, although the notochord is present
and expresses ShK Despite the absence of a floor plate and lack of Shh expression in the
ventral midline ofthe neural tube, the pattem of cell differentiation along the dorsoventral
axis, outside the ventral midbrain appears normal in Gli2 homozygotes, stiggesting the
signais from the notochord can be sufficient for the early dorso-ventral differentiation of
the ventral spinal cord and hindbrain. In the Gli2 knockout mice, the number of 5-HT and
dopaminergic neurons that were generated in the region flanking the floor plate, was
markedly reduced, indicating either a direct requirement for G1i2 in the precursors of these
cells or a requirement for a normal floor plate for a normal development ofthese neurons
(Matise et aï., 199$).
At early ages, Glu is expressed tbroughout the neural tube, including ventral
midline cells and receives the Shh signaIs from notochord. Ectopic expression of Gli 1 in
the dorsal midbrain and hindbrain ieads to activation of ventral neural tube markers and to
the formation of ectopic dorsal clusters of 5-HT and dopaminergic neurons in the neural
tube (Hynes et al., 1997).
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1.5.3 Other transcription frictors involved in 5-HT neuron development
Transcription factors involved in 5-HT neuron deveiopment may 5e divided into 2
groups: I) the factors that are necessary to generate 5-HT neuron precursors, like Nkx2.2,
Nkx6. 1, or Mashi; and II) factors that are required for 5-HT subtype selection and ultimate
differentiation of 5-HT fleurons, like Mashi, Gata2, Gata3, Lmxib, Peti, and Otx2.
Nkx2.2 (a homeodomain transcription factor that acts downstream of Shh signaling)
is necessary for initiating the specification of ail 5-HT neurons in the raphe, except the DR.
In Nkx2.2 knockout mice, only DR 5-HT neurons are present and ail others are missing
(Cordes, 2005).
The earliest 5-HT neurons that develop adjacent to the mid-hindbrain boundary at
the ventral midline are in rhombomere 1 (ri). This group of 5-HT neurons sends ascending
projections to the forebrain. During 5-HT neuron development in chick embryo, Nkx2.2
cooperates with another transcription factor, Nkx6. 1, to induce the expression of the zinc
finger transcription factor Gata2 in ventral ri. Gata2 is sufficient to activate transcription
factors Gata3, Lmxib and Peti and induce 5-HT neurons in ri. Gene Imockout smdies
showed that 5-HT neurons in ri are specified normally in Gata3 mutant embryos, but are
completely absent in mid-hindbrain explants derived from Gata2 nuli mice. These data
suggest that Gata3 is unable to specify 5-HT neurons in the absence of Gata2. The loss of
5-HT neurons in the caudal raphe nucleus of Gata3 knockout mice indicates that Gata3 has
a role in the development of caudal 5-HT populations (Craven et al., 2004; Scott &
Deneris, 2005)
Lmxlb is a LIM homeobox-containing gene that is expressed bilaterally in the
ventral part ofhindbrain, including the floor plate, at EiO in mouse. At E13.5 and later
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stages, Lmxlb is present in the raphe nuclei and adjacent reticular formation. The
expression pattem ofLmxlb is similar to the 5-HT expression pattem in the hindbrain,
during embryonic deveiopment. In Lmxlb knockout mice, the differentiation of 5-HT
neurons is completely interrupted. The expression of Shh and Nkx2.2 are normal in these
animais, supporting the idea that Lmxlb acts downstream oftheses two genes. However,
Gata3 expression is largeiy lost in Lmx lb mutant mice in the caudal raphe nuclei,
indicating that it acts downstream ofLmxlb in the development of some caudal 5-HT
neurons (Cheng et al., 2003; Ding et aÏ., 2003).
The transcription factor Otx2 determines the mesencephalic, versus metencephalic
(cerebellumlpons) territories during embryogenesis. It is involved in positioning and
maintaining the isthmic organizer at the border between midbrain and anterior hindbrain.
Otx2 expression regulates the location and size ofdopamine and 5-HT neuron populations.
If Otx2 is expressed more caudally, the isthmic organizer also shifis caudally, and the
number of midbrain dopamine neurons augments, at the expense ofrostral 5-HT neurons of
B7, or DR. If Otx2 expression is reduced, the isthmic organizer shifis rostrally and the
rostral 5-HT population expands into the rostral region (Brodski et al., 2003).
Otx2 expression is maintained long afier this organizer is established. Experiments
on Otx2 knockout mice revealed that Nkx2.2 and Shh are abnormally co-expressed in
midbrain and hindbrain neuronal progenitors of these mice and give rise to ectopic 5-HT
neurons (Nkx2.2 expression being normally limited to bindbrain progenitors). Ectopic
Nkx2.2 may be responsible for the abnormal formation of 5-HT neurons in the midbrain. In
agreement with this hypothesis, removal ofNkx2.2 in Otx2 mutant mice, resulted in the
disappearance ofectopic midbrain 5-HT neurons. These resuits suggested that Otx2
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normally prevents 5-HT development in the midbrain by limiting the expression ofNkx2.2
(Vemay et al., 2005).
Ascii (or Mashl) is a basic helix-loop-helix protein that is expressed along with
Nkx2.2 in fleurai precursors of hindbrain that generate 5-HT neurons later during
development. Ascii together with Nkx2.2, is also required for the phenotypic specificatïon
of 5-HT neurons in the neuroepithelium. Experiments on Gata3 mutant mice also showed
that Gata3, Lmx lb and Peti act downstream of these transcription factors (Pattyn et aï.,
2004).
1.5.4 Molecules that influence the growth of5-HT axons
Although major progress has been made recently in the identification of factors
specifying the fate of 5-HT neurons, liffle is currently known about the molecules that
guide 5-HT axons to their targets. This subject has been reviewed by my colleague, B.
Sharif Askari, in his own Master’s thesis (Sharif Askari, 2006). I will thus only present a
brief summary of the question..
Some trophic factors have been shown to have some effect on the 5-HT axonal
projections in the forebrain. One of them is brain-derived neurotrophic factor (BDNf),
wfflch may promote terminal 5-HT sprouting in the hippocampus and whose receptor,
TrkB, mRNA is expressed in DR 5-HT neurons (Madhav et al., 2001). Brain-derived
neurotrophic factor was shown to promote the sprouting of 5-HT axons afier local chemical
insult in cerebral cortex, and to induce ifie expression of 5-HT markers, such as tryptophan
hydroxylase (Rios et al., 2006).
Another trophic factor, S1003, a glia-derived calcium binding protein, was also
shown to have a trophic activity on 5-HT neurons in ceil culture, where it enhanced the
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neurite extension and 5-HT uptake capacity of neurons dissociated from the mesencephalic
raphe (Azmitia et aÏ., 1990). However, experiments on mice with mutant Si 00E3 showed no
significant difference in the number or morphology of 5-HT neurons compared with wild
type animais (Nishiyama et al., 2002).
Glial ceil line-derived neurotrophic factor (GDNf) family was also shown to have a
trophic activity on 5-HT neurons from the ventral mesencephalic area, increasing their
soma size, number of primary neurites and iength of 5-HT axons (Ducray et aÏ., 2006).
Nevertheless, the mechanisms of 5-HT axonal guidance to their various targets
remain largely unknown. Previous in vitro experiments in our iaboratory suggested that
GPI-linked celi membrane proteins may influence the guidance of 5-HT axons. Some
candidate membrane proteins that could act as guidance cues include the ephrins (see
below), semaphorins (Tamagnone et al., 1999), netrins (Baraliobre et al., 2005), ceil
adhesion molecules like cadherins or immunoglobulin CAMs (Litwack et al., 2004) and
Siits (Bagri et aL, 2002)
Up to now, Sut-1 and Sut-2 are the only axon guidance cues to have been involved
in the guidance of ascending 5-HT axons to forebrain. Sut proteins, in combination with
their receptors, the roundabouts or Robos, are known as a midiine repelients reguiating
midiine commissural formation. In sut] and slit2 double mutant animais, the ascending
fibers of DR 5-HT neurons normally projecting to the forebrain, are displaced ventrally as
they course through the diencephalon. These data suggest that the loss of Sut function
affects the development of the 5-HT axons, while they grow rostrally into the forebrain
(Bagri et al., 2002). In addition, 2 Robo receptors, Robo2 and Robo3 interact with the zinc
transcription factor, eagle, to regulate 5-HT neuron differentiation. Loss of robo2/3
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ftmnction causes a loss of SERT expression in 5-HT neurons in embryos (Couch et al.,
2004).
Recent neurochemical studies showed that the 5-HT levels in the striatum of mice
expressing a dominant-negative fonn of the EphA5 receptor, were significantly reduced in
comparison with wild type animais. No change was detected, however, in the frontal cortex
or hippocampus of these animais. These mutants aiso dernonstrated behavioural deficits
(two-way active avoidance leaming) compared to controls (Halladay et aÏ., 2004). Thus,
with the recent observations of Sharif Askari, in our laboratory, this evidence suggests that
ephrins and their receptors might be involved in 5-HT axon guidance or growth in
forebrain.
1.6 Ephrins and Eph receptors
Eph receptors belong to the superfamily oftyrosine kinase receptors and take part in
various aspects of morphogenesis, angiogenesis and tumorigenesis in different organs. Eph
receptors and their ephrin iigands are widely expressed in the developing and aduit nervous
system. They are implicated in contact repulsion and attraction between adjacent ce!!
surfaces and in the guidance of migrating neurons and growing axons. Ephrins are
subdivided into 2 subciasses: ephrin-As (A1-A6) are attached to the outer celi surface by a
glycosylphosphatidylinositoi (GPI) anchor and ephrin-Bs (31-33) are transmembrane
proteins. Ephrin-As in general have a high affinity for EphA receptors (Al -A 10), whereas
ephrin-Bs prefer EphB receptors (EphBl-B6). The latter rule lias 2 exceptions: EphA4
having aiso a high affinity for ephrin-B2 and -33, and EphB2 for ephrin-A5 (Klein, 2001;
Blits-Huizinga et aï., 2004; Hirnanen et al., 2004).
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1.6.1 Ephrin and Eph signaling pathii’ays
Eph receptors are type-1 transmembrane proteins. Their extra-cellular part contains
a highly conserved N-terminal dornain, followed by a cysteine-ricli region. and then by 2
fibronectin type III repeats (involved in receptor dimerization and Cis interactions with
other proteins like NMDA receptors). Their intraceilular region contains ajuxta-membrane
domain. a conseiwed tyrosine kinase domain, a sterile Œ-motif ($AM) domain and a PDZ
binding domain (Himanen & Nikolov, 2003).
There are 3 types of signaling pathways associated with Eph receptors: forward
signaling, reverse signaling, and cross-talk signaling.
In forward signaling, the first step is the binding of an epbrin ligand and an Eph
receptor located on closely apposed ceil surfaces. The activated Eph starts downstream
signaling through autophosphorylation that regulates actin dynamics via small guanosine
tri-phosphatases (GTPase) ofthe Rho family (Martinez & Soriano, 2005). These GTPases
act as moiecular switches, being inactive in the GDP-bound state, and active in the GTP
bound state. Guanine nucÏeotide exchange factors (GEFs) that promote the exchange of
GDP for GTP, facilitate this activation pathway, whereas this process is inhibited by
GTPase activating proteins (GAPs). The most important members ofthe Rho famiiy are
RhoA, Rac I and Cdc42. RhoA regutates stress fiber and focal adhesion formation and ccli
contractibility, whereas Rad and Cdc42 respectively take part in the formation ofthe
protrusive structures, lamellipodia and filopodia (Noren & Pasquale, 2004).
Ephexin is a GEF, iinking EphA to RhoA. When an EphA binds to an ephrinA, the
catalytic activity of ephexin increases and induces activation of RhoA and down regulation
ofRaci and Cdc42 and leads to ccli morphology changes (Shamah et ai., 2001).
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EphB receptors bind to other exchange factors, like intersectin or kalirin that
activate Rac2 and Cdc42, respectively. In hippocampal neurons, EphB interactions with
these exchange factors regulate dendritic spine morphogenesis. EphB2 also cooperates with
neural Wiscotte-Aldrich syndrome protein (N-WA$P), to activate intersectin. N-WASP
binds to actin polymerising complex AP 2/3 in the presence of activated Cdc42 and induces
actin filament assembly and branching. Kalinn is predominantly expressed in the nervous
system. In immature hippocampal neurons, attachment of ephrin-B 1 to EphB induces
accumulation of kalirin in the postsynaptic region to induce dendritic spine morphogenesis.
Phosphorylated kalirin itself regulates the activation ofRaci and Pak (a Rad downstream
effector). Activated kalirin, Rad and ?AK are necessary factors for the induction of
dendritic spine maturation via ephrin-B signaling. Eph receptors also regulate the activity
of the Ras family of GTPases that are involved in several developmental processes,
including axon guidance and ceil adhesion. In most ceils, Eph receptors negatively control
phosphorylation ofthe Ras-MAP kinase pathway (Noren & Pasquale, 2004).
The reverse signalling pathway is induced following the activation of an ephrin
ligand (then acting as a receptor) by an Eph receptor. for ephrin-Bs, this pathway is
phosphotyrosine- or PDZ-dependent. Ephrin-3 phosphorylation can be mediated by a
tyrosine kinase of the Src family. Ephrin-A ligands, although deprived of any intraceliular
domain, also have reverse signalling potentials. for exampte, activation of ephrin-A2 or
-A5 by EphA3 resuits in a 2—integrin-dependent increase in laminin adhesion capahility of
the ceil expressing the ephrin (Martinez & Soriano, 2005).
Cross-talk signaling. or interaction between Ephrin/Eph and other proteins on the
same ccli surface, in Cis, is thought to be important in synaptogenesis and ccli adhesion.
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For example, during embryonic life in mice, EphB2 and -B3 cooperate with the tyrosine
kinase Ryk to bind to the ccli junction-associated, PDZ-domain-containing protein, Af6.
This attachment is important in ccli binding. Ryk knockout mice present a clefi palate
phenotype similar to that observed in EphB2/B3 double knockout mice; indicating a
cooperation among these proteins in palate formation (Murai & Pasquale, 2003). EphB
receptors aÏso induce aggregation and phosphorylation ofNMDA receptors in synapses and
initiate postsynaptic maturation during development (Martinez & Soriano, 2005).
1.6.2 Functions ofephrin/Eph in CNS
1.6.2.1 Segmentation and tissueformation:
Severai Ephs and ephrins are expressed in a segmented pattem in hindbrain
rhombomeres and in somites, and have active roles in the pattem formation of these areas
by both forward and reverse signaling pathways. EphA4 and EphB2-33 are highly
expressed in rhombomeres r3 and r5, and their potential ligands, ephrins-B l-33, are present
in r2, r4 and r6. Reverse signaling keeps EphA4 expressing celis at the boundary ofr2, r4
and r6 by a repulsion mechanism. The ligandlreceptor interaction at the interface of
adjacent rhombomeres has an important role in establishing the precise border between celi
populations and organization ofeach segment subunit. Disruption ofephrin!Eph
interactions or signalisation, causes major defects in hindbrain segmentation (Martinez &
Soriano, 2005).
1.6.2.2 Cet! migration and adhesion:
Ephrins and Ephs control both cranial and trunk fleurai crest ceil migration. In early
stages of development the trunk neural crest ceils of rodents and chick migrate through the
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anterior, but flot the posterior haif of each sornite. The presence of ephrin-B 1 and -B2 in the
posterior haif of each sornite represents a repulsive signal for neural crest ceils that express
EphB receptors. In Xenopus, forward signaling of EphA4 acts as a repulsive signal and
guides branchial neural crest ceils: in a dominant negative mutant of EphA4, only the
EphA4 expressing neural crest ceils are affected, not those expressing the ephrins (Davy et
al., 2004).
L 6.2.3 Synaptogenesis:
Ephrins and Ephs are expressed in aduit as well as developing nervous system, and
play critical roles in modulating synapse maturation and function. They are located in both
axonal and dendritic compartments (Bouvier et aï., 2007; Tremblay et al., 2007). Ephrins
may also be present in pre- and post-synaptic compartments, as well as in astrocytes.
Expression of ephrins on glia may have an active role in neuron-glia cross-talk (Murai &
Pasquale, 2004). Dendritic spines have a very dynamic structure, they go tbrough
remodelling even in mature neurons. Actin neurofilaments have a leading role in the shape
and motility of spines and, as mentioned before, several Eph signaling pathways modulate
actin neurofilaments remodelling and can take part in structure formation of dendritic
spines in aduit and developing neurons (Murai & Pasquale, 2004).
EphB receptors regulate the maturation of filopodia into dendritic spines. They
induce the clustering and also modulate NMDA-dependant calcium influx (by activating a
pathway via Src kinase farnily) and have important roles in synaptic transmission (Martinez
et al., 2005).
Triple EphB 1, -82 and -B3 knockout mice fail to form mature spines by postnatal
day 21, and instead retain immature filopodial processes. These triple knockout mice
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displays altered ciustering ofboth f-actin and post synaptic density-95 protein (PSD-95) in
their long, thin dendritic protrusions. PSD-95 and the afferent terminais, Iabeled by
presynaptic marker synaptophysin, then distribute along the dendritic shafts, instead oftheir
usual association with spines (inside or apposed to), as in wild-type mice, indicating
abnormal synapse formation (Lippman & Dunaevsky, 2005).
1.6.2.4 Axonal guidance andformation oftopograpltic maps
Both ephrin-As and -Bs take part in retinotectai mapping by chemorepellent as weli
as chemoattractant signaling. In retinal ganglion celis, EphA receptors are expressed in a
iow nasal (or rostral for laterally positioned eyes) to high temporal (or caudal) levels; while
ephrin-As have a low rostral to high caudal expression in the visual tectum. During
development, nasal retinal ganglion ccli axons project to the caudal tectum, while temporal
retinal ganglion celi axons project to rostral tectum. EphB receptors and ephrin-B ligands
also contribute to the organization of the dorso-ventral axis of the retino-tectal projection,
but by chemoattractive mechanisms: ventral retinal ganglion celis, with higher levels of
EphBs, project to the medial part ofthe colliculi, expressing high levels ofephrin-Bs
(Lemke & Reber, 2005). Similar mechanisms are involved in the formation of retino
thalamic maps (feldheim et al., 199$).
A particular mechanism exists for the formation ofthe thalamocorticai fibers. The
axons from rostrai thalamic nuclei project to the rostral neocortex, whiie caudal (visuai)
thalamic nuciei innervate caudal visuai cortical areas. This pattern is estabiished during the
growth of thalamic libers in the basal forebrain, towards the cerebral cortex, when EphA4
receptors on thalamic libers rneet with a graded distribution ofephrin-A5 in the ventral
telencephalon (Dufour et al., 2003).
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During CNS developrnent, EphA$ guides commissural axons from superior
colliculus to pass the midiine and project to their targets in the contralateral inferior
colliculus. In absence of EphA8, these neurons continue their projections through the
ipsilateral inferior colliculus and reach the spinal cord (Park et aÏ., 1997).
The entorhino-hippocampal projections are regulated by ephrin-AIEphA. The
entorhinal axons and their target hippocampal regions express EphA receptors and ephrin
A ligands, respectively. Ephrin-As are localized in the hippocampal stratum radiatum and
the dentate inner molecular layer, where commisural/associative, but not entorhinal
projections, terminate. In vitro studies showed that outgrowth of entorhinal neurites was
inhibited by ephrin-A3. These resuits, together with the expression of EphA5 by entorhinal
projecting ceils, suggest that EphA5-expressing entorhinaÏ axons are repelled by their
interaction with ephrin-A expressing dendrites in inappropriate target layers. In contrast to
ephrin-A3, ephrin-A5 exerts minor effects on outgrowth and guidance of entorhinal axons
and entorhinal axons are not disrupted in ephrin-A5 knockouts (Martinez et al., 2005).
In rodents, corticospinal tract axons originate from layer V in neocortex, and project
to forebrain, midbrain, hindbrain and at different levels of spinal cord. In EphA4 knockout
mice, projections of corticospinal axons show several defects at medullar and spinal cord
levels, and these animais show Ioss of coordination in hindlimb movements with a
kangaroo-like gait (Dottori et al., 199$).
EphrinlEph interactions have active roles in guiding topographie projections from
hippocampus to lateral septum. In late ernbryonic and early postnatal days, EphA3-A7
receptors show graded expression from lateral to medial regions of hippocampus and
ephrinA2, -A3 and -A5 expression increases from dorso-medial to ventro-lateral area of
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lateral septum. This hippocampo-septal topographic map is disrupted in mutant mice
expressing a dominant negative form ofEphA5 (Yue et al., 2002; Martinez et al., 2005).
1.7 Objectives of present work
In the present study, we worked on the hypothesis that ephrin-As take part in axonal
guidance of 5-HT axons in forebrain and midbrain, during deveiopment, based on recent
celi culture observation in our laboratory (Sharif Askari, 2006). Indeed, this work showed
that celi membranes extracted from the neonatai Ctx, Str or VM couid influence the growth
of 5-HT axons from the dissociated DR. This axon guidance activity of the ccli membranes
was dismpted by a prior treatment with the enzyme PI-PLC, which removes GPI-anchored
ceil membrane proteins, and reduced by treatment with EphA3-Fc, a fusion protein
comprising the extracellular domain ofEphA3 and the Fc domain ofhuman
immunoglobulins and known to biock specifically the binding of ephrin-As to EphA
receptors. We thus hypothesize that 5-HT axons bear EphA receptors that can be activated
by ephrin-A ligands present at the surface ofthe ccli membranes in the target brain regions,
Ctx, Str or VM. The specificity ofthe projections is most likely dependant on the
combinatoriai expression ofdifferent sets ofEphA receptors by individual 5-HT axons and
expression of complementary sets of ephrin-As in the different target regions.
for the current work, we foiiowed 2 objectives. The first one was to confirm the
presence ofephrin-As in the target brain regions (Ctx, $tr and VM), particularly in
membrane extracts from these regions, that were used as substrates for 5-HT neuronal
primary cultures. This part of the experimentation was donc using Western Blotting
techniques. The second objective was to determine the expression of EphA receptors in the
DR, where 5-HT neurons projecting to the Ctx, Str and VM are located. for this, we used
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in situ hybridization with DiG-labelleU riboprobes. We already had plasmids containÏng
constructs for the synthesis of EphA3, EphA4 and EphA5. However, we had to re-insert the
EphA4 construct in another plasmid. to be able to synthesise a suitable control sense probe
for this molecule. We also prepared a new construct for the EphA7 mRNA.
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2. Materials and methods
2.1 AnimaIs
Ail experimental procedures were approved by the Ethics Cornmittee on the use of
animais of the Université de Montréal (Comité de déontologie de 1 ‘expérimentation sur tes
animaux - or CDEA).
Embryonic day 15 (El 5) and newborn (P0) Sprague-Dawley rats, and P60 C573L/6
mice were purchased from Charles-River (Montréai, QC, Canada).
For Western Blotting, 15 newbom rats were quickly decapitated with sharp scissors.
For in situ hybridization on embryonic brain sections, a pregnant rat was sacrificed
by C02 inhalation, the heads ofthe fetuses were dissected and immersed into 4%
paraformaidehyde (in 0.1 M sodium phosphate buffer, pH7.2, or PB). For newborn and
aduit cases, 1 P0 rat and I aduit mouse were deeply anaesthetized with 0.3 ml/lOOg, or
0.5 ml/lOOg, respectively, ofa mixture containing one part fentanyl citrate (Hypnorm,
Janssen pharmaceutica, Beerse, Belgium), one part midazolam (Versed, Roche
Biotechnology), and 2 parts water. They were perfused transcardially with 4%
paraformaldehyde in P3, aller rinsing the vasculature with sodium phosphate-buffered
saline (PBS, pH 7.2). Brains were extracted and kept in the same fixative solution ovemight
at 4°C and then embedded in paraffin.
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2.2 Detection of EphA4, EphA5 and EphA7 mRNA by in situ hybridization
2.2.1 Preparation ofconstructs and insertion into plasmids
2.2.1.1 EphA4 construct
The EphA4 constmct was available in the laboratory (generous gift of Dr. Elena
Pasquale, Burnham Institute, LaJolla, CA), but we had to insert it into a different plasmid to
be able to efficiently synthesize both sense and antisense probes. This construct, a 313 bp
fragment from nucleotides 97 to 409 ofthe gene, had been originally inserted into the
pCR2.1-TOPO plasmid, but with only the T7 promoter controlling the transcription ofthe
antisense riboprobe. b obtain both sense and antisense riboprobes with equal efficiency,
we inserted this cDNA fragment in either directions into 2 different pGEM-7Z (+)
plasmids, so both sense and antisense probes could be transcribed under the control of the
T7 promoter.
for the antisense probe, the EphA4 fragment was extracted from the original
plasmid, pCR2. 1-TOPO, by digestion with Spel and XhoI restriction enzymes (fermentas
Life Science) in their respective specific buffers, for 2 h at 3 7°C. In parallel, the recipient
pGEM plasmid was prepared by digestion with XbaI (fermentas) and XhoI restriction
enzymes (to open the site for EphA4 insertion).
for the sense probe, both the donor pCR2. 1-TOPO and the recipient pGEM
plasmids were digested with Hindili (fermentas) and XhoI.
To prevent reverse binding of the 2 free sites of the open pGEM plasmid, following
digestion, these sites were de-phosphorylated by incubation with shrimp aikaline
phosphatase (fermentas) for 30 mm, at 37°C. Afier gel electrophoresis ofthe digested
products (digested pGEM and EphA4 fragment, f ig. 1), the DNA concentration ofeach
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band was measured with the Gel Doc 2000 image analysis system (a CCD camera and
Quantity One image analysis software measuring the density and size of the spots on the
gels; from BioRad). The bands were then removed with a scalpel and purified with the
QlAquick Gel extraction kit (QIAGEN Inc., Mississauga, ON).
To ligate the FphA4 fragment into the pGEM plasmid, 2.2 il ofplasmid (0.37 ig/
pi), and 42 pi ofEphA4 fragment (2.11 j.tgl pi) were mixed with 1 t1 of 14 DNA ligase
(1 U/pi; Fermentas), 5.5 jil of 1OX ligation buffer (400 mM Tris-HC1, 100 mM MgCl2,
100 mlvi DIT, 5 mM ATP; pH 7.8; provided with the enzyme) and 4.3 tl H20, ami
incubated for I h at room temperature.
Then, E.coli DHYO competent celis were transformed by mixing 0.1 ml ofthe
bacteria (3.75 x bacterialml) with 30 pi ofthe plasmid (0.3 1 jig/ pi) containing the
EphA4 construct, and submitting them to a thermie shock: i.e. sequential incubation at 4°C
for 30 mm, at 42°C for 2 mm, and at 4°C for 2 min. Then 0.5 ml ofsterile Luria-Bertani
medium (LB medium, 10 ig tryptophan, 5 ig yeast extract, 10 ig NaC1, and 200 jil 10 M
NaOH) was added to the mixture and incubated for I h at 37°C. Then, 100 or 200 cl ofthe
ceil suspension were sown into 2 separate gelatine-coated Petri dishes, which were
incubated ovemight under gentle agitation, at 37°C. The next day, 10-20 colonies were
randomly chosen and scratched with pipette tips, under sterile conditions (near a flame),
and each transferred into a sterile 1.5 ml Eppendorf tube containing 1.0 ml of LB medium.
The DNA was then extracted. For this, the tubes were centrifuged twice at 17 000 x g
(Thermo IEC, Microlite) for 1 min and the supernatant was discarded. The final pellets
were re-suspended in 100 pi of lysing solution, or STET (8% Sucrose, 5% Triton X-100,
50 mM fDTA, 50 mM Tris-HC1, pH 8), boiled during 1 mm, and centrifuged again (same
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speed) for 1 min. The pellets were adjusted with 5 jil of 5 M NaCI and 105 pi isopropanol,
to precipitate the DNA. Eppendorf tubes were placed at -80°C for 10 mi and centrifuged
again for 10 min. DNA in the pellet was washed with 500 pi of 70% ethanol, and
centrifuged for 2 min. The pellet was re-suspended in 50 tl of TE buffer (Tris/EDTA;
10 mM Tris-HCL pH 8, 1 mM EDTA) containing RNaseA (10 mg/ml). The final products
were pGEM plasmids with the T7 promoter controlling the synthesis ofeither sense or
antisense EphA4 inserts (Fig. 1, A, B and C).
2.2.1.2 EphA5 construct
The constmct for EphA5 had already been prepared by Cyrinne Ben Mamou, a
former student in our laboratory, and Damien Barbas in the laboratory of Dr. L.
DesGroseillers, and inserted into the pZAPA-TA plasmid, derived from the pBluescript
SK+ plasmid (Barbas et al., 2002). A 0.91 kb mouse cDNA fragment, extending from
nucleotides 3297 to 4206 ofthe EphA5 gene (Genbank access U07357), had been extracted
from Mus musculus Balb/c DNA. Synthesis ofthe sense and antisense probes was under the
control of the T3 and T7 promoters, respectively (fig. 1 3, D).
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EphA4 riboprobes
12216bp
h.
1636bp
Sense Antisense Marker
(C)
Figure 1. Production of the EphA4 and EphA5 riboprobes
A) Linearized pGEM-EphA4-Reversed plasmid following digestion with Hindili restriction
enzyme for production of the EphA4 sense probe. B) Linearized pGEM-EphA4 plasmid
(lane 1), following digestion with Hindili restriction enzyme for synthesis ofthe EphA4
antisense probe; and linearized pZapata-EphA5 plasmid, digested with NotI restriction
enzyme for the synthesis ofthe EphA5 antisense probe. C) DiG-labelled EphA4 sense and
T
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antisense riboprobes. D) DiG-Ïabelled EphA5 sense and antisense riboprobes (“CtI” is
control DNA from the Roche RNA DiG labelling kit).
2.2.1.3 EphA 7 construct
The EphA 7 construct was flot available. In collaboration with frédérique Badeaux,
in Dr. L. DesGroseillers’s laboratory, we prepared a construct by generating a 499 bp DNA
fragment of the EphA 7 gene by a polymerase chain reaction (PCR) from genomic DNA
extracted from a culture ofNeuro2A celi une. Sequence-specific sense and antisense
primers (EphA7 sense, 5’-AAG AAT TCG TGG GAA GAA AIT AGI GGT 11G-3’; and
EphA7 antisense, 5’-TTG AAT TCG GAA AGA CAG CIA AGT TCT CAA-3’;
purchased from Integrated DNA Technologies, Coralville, TA) were used to amplify the
DNA fragment. The PCR was done with the Phusion kit (High-Fidelity DNA Polymerase,
Finnzymes, OY, finland), following the manufacturer’s instructions. Briefly, 5 j.il of
Neuro2A DNA (2 ng/tl), 10 il of Phusion buffer, 1 .c1 dNTP (nucleotide triphosphate, final
concentration: 200 1tM), 31.5 lii F120, I j.d sense primer (30.2 ig/OD260), I il antisense
primer (30.6 ji.g/0D260) and 0.1 tl Phusion DNA polymerase (2 U/pJ) were mixed together
and incubated in a 13 Thermocycler (Bïometra, france), again according to the
manufacturer’ s parameters. The day after, the PCR product was electrophoresed in a 1%
agarose gel containing ethidium bromide, in presence of 2 DNA markers, respectively
100 bp (Invitrogen) and I Kbp (New England Biolab). The band containing the PCR
product was cut out from the gel and the DNA was extracted and purified using the
QlAquick Gel Extraction Kit (F ig. 2A). Next, phosphorylation of EphA 7 PCR product was
performed on 50 tl PCR product, 1 tl T4 polynucleotide kinase (10 U/t1; Fermentas),
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6.5 tl IOX reaction buffer A (provided with the enzyme), 6.5 pi ATP (10 mM), 1 pi F120
for 20 min at 3 7°C.
EphA 7 was inserted into the pBluscript II KS (+7-) pïasmid, with T7 and T3
promoters. for this. the plasmid was digested with EcoRV restriction enzyme (fermentas;
pi mini pBluescript KS, 10.5 pi F120, 2 pi Buffer Red, 0.5 pi Ec0RV) during 2 h at 37°C.
Dephosphorylation of the digested plasmid was done in the presence of 0.5 pi of shrirnp
aikaline phosphatase (1 U/pi), 5 pi 1OX Reaction buffer (provided with the enzyme) and
24.5 pi F120, for 30 min at 37°C. After the respective gel electrophoresis of the digested
pBluescript and EphA 7 fragment, the DNA concentration of each band was measured in the
Gel Doc 2000 image analysis system. The bands were then removed with a scalpel and
purified with the QlAquick Gel extraction kit.
for the ligation ofthe EphA 7 fragment into the pBluescript plasmid, 8.5 pi of the
plasmid (8.8 nglpi), and 43 pi of the fragment (2.9 ng4d) (to obtain 75 ng of plasmid and
125 ng of EphA 7 fragment, or a ratio of 10 EphA 7 fragments for each plasmid) were mixed
with 1 pi of the T4 DNA ligase (1 U/pi), 6 pi of 1 OX ligation buffer (400 mM Tris-HC1,
100 mM MgC17, 100 mM DTT. 5 mM ATP pH 7.8) and 1.5 iii F1,0. ami incubated for 1 h
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2.2.2 Synthesis ofantisense and sense riboprobes
b synthesize the antisense and sense riboprobes, 15 .d of the respective pGEM
plasrnids (0.3 j.ig/tl) containing the EphA4 fragment in one or the other orientation were
linearized with 2 d ofHindlll restriction enzyme (l0U/il), 2 .tl ofthe 1OX REact 2 buffer
provided with the enzyme, and I .t1 F120, for 2 h at 37°C. Gel electrophoresis (1% agarose
gel with ethidium bromide) was done in the presence of 1 Kb DNA Iadder rnarker
(Invitrogen) and the digested plasmids. Afler migration at 120V for 45 min the gel was
visualized under UV light. The band corresponding to each plasmid was cut with a scalpel.
The DNA was extracted and purified from the gel by using the QIAEX II Gel Extraction
Kit (QIAGEN), according to the manufacturer’s instructions. Antisense and sense
riboprobes were produced by in vitro transcription of the linearized plasmids, using the 17
polymerase (DiG RNA labelling kit; Roche). following the manufacturer’s instructions,
1 jil of linearized plasmid was incubated with 2 tl fOx NTP labelling mixture, 2 p.l I Ox
transcription buffer, I iI RNase inhibitor (20 Ulpi), 2 .iI RNA T7 polymerase (20 U/il) and
3.5 j.tl ofH2O, at 37°C for 2 h. Two microliters ofDNase-I (10 U/il) were then added to the
mixture, to remove template DNA. The RNA transcripts were analysed by agarose gel
electrophoresis with ethidium bromide staining (fig. 1).
for EphA5, 15 d ofpZAPA-TA plasrnid (0.7 ig/.tl) was linearized with 2 j.tl of
either Not-I (8 U4tl, Amersham Pharmacia Biotech) or Kpn-I (10 U/tl Invitrogen)
restriction enzymes, 2 pi of their respective buffers (1 OX H buffer, I OX REact 4 buffer),
and I pi H,O, for 2 h at 37°C. Gel electrophoresis and DNA extraction was perforrned as
above. Antisense and sense riboprobes were respectively produced by in vitro transcription
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of the NotI-linearized plasmid, using the T7 polymerase, or the KpnI-linearized plasmid
using T3 polymerase.
for EphA7, 15 d of either pBluescript antisense plasmid (0.36 p.g/d) or pBluescript
sense probe (0.47 ig4i.l) were digested with 2 d of either Hindili or Not-I restriction
enzymes, 2 pi of their respective buffer, and 1 pi I-120, as above. Gel electrophoresis and
DNA extraction was done as above. The antisense and sense riboprobes were respectively
produced by in vitro transcription, using T7 polymerase (on HindIII-linearized plasmid), or
T3 polymerase (on Not-I-linearized plasmid) from the Roche DIG RNA labelling kit (Fig.
2).
EphA 7
3054bp
b..—
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Figure 2. Production of EphA7 riboprobes
A) EphA 7 fragment extracted from Neuro2A ce!! une and amplified by PCR. B) SK-EphA 7
plasmid linearized by digestion wiffi Hindili (for antisense riboprobe) or with NotI (for
sense riboprobe) restriction enzymes. C) DiG-labelled EphA 7 sense and antisense
riboprobes, and control DNA (Ct!).
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2.2.3 In situ hybridization
In situ hybridization was performed on 6 jim-thick coronal brain sections
(embryonic and neonatal rat, and aduit mouse). Sections were de-paraffinated in 3 baths of
xylenes (10 mm) and gradually re-hydrated by successive baths ofethanol 100% (2x5 mm),
95%, 70%, 50% and 30% (3 min each), and finally in SSC (Sodium chloride 300 mM;
sodium citrate 30 mM) 2X, pH 7.5 for at least 5 minutes. The hybridization solution
contained 40% formamide, SSC 4X, Denhardt solution 5X (Sigma-Aldrich), 150 tg!ml
salmon sperm DNA (Invitrogen), 250 ig!m1 yeast tRNA (Invitrogen), dextran sulfate 10%
(Sigma-Aldrich) and RNA probe I j.tg!ml. Iwo-hundred microliters ofhybridization
solution were applied onto each section, covered with a piece of Parafiim, and the slides
were incubated in a humid chamber at 52°C for 16-20 h. After hybridization, the slides
were rinsed twice in SSC 2X pH 7.5, and twice in SSC 0.1X pH 7.5 (52°C; 15 min each).
For the immunohistochemical detection of digoxigenin, the sections were first
incubated at room temperature with Tris-buffered saline (TBS; Tris-HC1 lOOmM, NaCI
lOOmM, MgC12 2 mM, pH 7.5) containing 1% bovine serum albumin (BSA), for 30 min. to
block nonspecific sites, and then incubated for I h at room temperature in TBS-BSA 1%
containing aikaline phosphatase-conjugated anti-digoxigenin antibody (1:500, Dig Nucleic
Acid Detection Kit, Roche). $lides were washed 3 times in TBS pH 7.5 (15 min each), and
once in TBS pH 9.5 (Tris-KCL 100 mM, NaC1 150 mM, MgCI2 5mM). Riboprobes were
visualized by the aikaline phosphatase reaction in the presence of nitro blue tetrazolium
chloride (N BI) and 4-bromo-4-chloro-3 indolyl phosphate (BCIP). The reaction was
stopped by rinsing in water for 10 min and the sections were air dried, and coverslipped
with DPX (Fluka, Buchs, Switzerland).
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2.3 Detection of 5-HT neurons by SERT immunohistochemistry
b detect 5-HT neurons in the DR, SERT immunohistochemistry was performed on
paraffin-embedded sections ftom the same animais. De-paraffinization and hydratation
steps were performed as above. Then, the siides were pre-incubated with penetrating and
blocking agents (0.3% Triton Xl 00, and 5% normal goat serum) for 2-3 h at room
temperature. The siides were incubated ovemight at room temperature in a humid chamber,
under 200 t1 ofPBS containing 5% normai rabbit serum, 0.3% Triton X100 and the anti-
SERT primary antibody (1:500, se-145$; Santa Cruz Biotechnology). The foliowing day,
siides were washed 3 times in PBS (5 min each), and incubated under 200 t1 ofa biotin
conjugated rabbit secondary antibody anti-goat immunoglobulins (1:500 in PBS; Jackson
ImmunoResearch) for 2-3 h. They were washed 3 times with PBS, and then incubated
under 200 ii ofa streptavidin-horseradish peroxidase (HRP) complex (1:1000 in PB,S;
Jackson) for 1 h at room temperature. After several washes in PBS and then in 50 mM
Tris—HCI, they were reacted with 400 jil of3-3’diaminobenzidine tetrachioride (Sigma
aldrich), dried and coverslipped with DPX.
2.4 Cortical, striatat, and ventral midbrain celi membrane extraction and Western
blotting
To test for the presence of ephrin-As in the membranes extracted from the 3
potential target brain regions examined in the laboratory (Sharif Askari, 2006), pieces from
each ofthe three regions (Ctx, Str, and VM) were dissected from neonatal rat brain (Fig. 3).
The dissected pieces were transferred to 1.5 ml centrifuge tubes containing Buffer H
(10 mM Tris-HCI, pH7.4, 1.5 mM MgCI2 and I mM spermidine with 40 tl protease
inhibitor Roche). The tissue was homogenized by severai strokes with P1000 and P200
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pipettes (Pipetman), followed by an ultrasonic bath (Branson 2200) for 5-10 min. The
homogenate was put on top ofa sucrose gradient (300 pi sucrose 5% and 700 111 sucrose
50%) and ultracentrifuged (Sorval Ultra pro 80; rotor AH650) for 20 min at 50 000 x g at
4°C. The band containing the purified membranes vas collected, washed in P35, and
centrifiiged for 10 min at 16 000 g (Eppendorf centrifuge 5415C), at 4°C (twice). The pellet
was re-suspended in 1 ml PBS and the protein concentration was deterrnined by using the
Lowry assay with ovalbumine as standard. Equal amounts ofpurified membranes
(20 j.tg/ml) were resolved in 12.5% SDS and transfered to nitrocellulose membrane in a
transfer apparatus (Mini protein II, Bio-Rad). Afier transfer, the membrane was blocked
with 5% non fat milk in TBS iX, pH 7.5 plus 0.05% Tween 20 (Bio-Rad) for 1h at room
temperature. Antibodies used included purified polyclonal rabbit anti-ephrin-A4 (1:500;
Zymed Laboratories, South San Francisco, CA), anti-ephrin-A5 (1:250; Zymed) and a
monoclonal mouse anti-actin (1:10 000; Sigma-Aldrich). Membranes were incubated with
either primary antibody in TBS-BSA 3% overnight. The next day, blots were rinsed 3 times
15 min with TBS containing 0.05% Tween-20 on a horizontal shaker. Secondary antibodies
used were HRP-conjugated Affinipure goat anti-rabbit IgG and HRP-conjugated goat anti
mouse IgG (1:5000; Jackson) and membranes were incubated for 1h at room temperature,
followed by 6 washes of 5 min in TBS containing 0.05% Tween-20, on a horizontal shaker.
Immunoreactive bands were detected on X-ray films (X-OMAT, Kodak diagnostic films)
using the chemilurninescent ECL Western Blotting Detection system (ECL Western
Blotting System, Amersham Biosciences).
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Figure 3. Dissection of VM, Str and Ctx tissues from neonatal rat brain (modified
from Petit et aI., 2005).
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3. Results
3.1. In situ hybrïdization in hippocampus
We used the hippocampus to test the efficacy of our riboprobes (EphA4, EphA5 and
EphA7), since most previous reports have shown strong expression of these receptors in
this specific brain region. In our experiments, the 3 receptors. EphA4, EphA5 and EphA 7
were strongly expressed in the aduit mouse hippocampus, as detected with the respective
antisense riboprobes. In the 3 cases, there was only very faint or no staining on sections
exposed to the sense riboprobes (Figs. 4-6).
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Figure 4. EphA4 in situ hybridization in aduit mouse hippocampal tissue.
A) EphA4 expression in the cerebral cortex, bippocampus and mesencephalon, as
detected with the EphA4 antisense probe. The area outlined is shown at bigher
magnification in B. C) Control in situ hybridization in an adjacent section, with the EphA4
sense riboprobe. The outlined area is represented in D, at higher magnification. CAl: CAl
field ofAmmon’s hom, CA2: CA2 field ofAmmon’s hom, Ctx: cortex, ec: extemal
—
EphM
Cb
ev
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(C) (D)
capsule, DG: dentate gyrus, LGN: lateral geniculate nucleus, MRN: median raphe nucleus.
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Figure 5. EphA5 in situ hybridization in aduit mouse hippocampal tissue.
A) EphA5 expression in the cerebral cortex, hippocampus and mesencephalon, as detected
with the EphA5 antisense riboprobe. The area outlined is shown at higher magnification in
B. C) Control in situ hybridization in an adjacent section, with the EphA5 sense riboprobe.
The outlined area is represented in D, at higher magnification. CAl: CAl field ofAmmon’s
hom, CA2: CA2 field of Ammon’s hom, cg: cingulum bundie, Ctx: cortex, ec: extemal
capsule, DG: dentate gyrus, PAG: preaqueductal gray matter LGN: lateral geniculate
nucleus, MRN: median raphe nucleus
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Figure 6. EphA7 in situ hybridization in aduit mouse hippocampal tissue.
A) EphA 7 expression in the cerebral cortex, hippocampus and mesencephalon, as detected
with the EphA 7 antisense riboprobe. The area outlined is shown at higher magnification in
B. C) Control in situ hybridization in an adjacent section, with the EphA 7 sense riboprobe.
The outlined area is represented in D, at higher magnification. PAG: periaqueductal gray;
LGN: lateral geniculate nucleus, MRN: median raphe nucleus
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3.2. Expression of EphA4, EphA5 and EphA 7 in the DR region of rat embryos
We used immunohistochernistry with anti-SERT and anti-5HT antibodies to localize
5-HT neurons in the DR. Unfortunately, this approach dud flot work on ernbryonic tissue,
despite the fact that previous in vivo as well as in vitro studies had shown that 5-HT
neurons of the DR are already differentiated at E 15 and immunoreactive for both markers,
sending projections to some regions of the CNS (Liu & Lauder, 1991; Rajaofetra et al.,
1992). Therefore, we had to rely on the Atlas ofthe Developing Rat Nervous System
(Paxinos et aï., 1994) and the Chemoarchitectonic Atlas of the Developing Mouse brain
(Jacobowitz & Abbott, 1992) to identify the DR in the sections of embryonic brain.
In situ hybridization with the 3 antisense riboprobes, showed mRNA expression of
the 3 receptors in the DR of El 5 rats (f igs. 7-9). Ail 3 receptors were also extensively
expressed in the surrounding regions of the brainstem, including the superior and inferior
colliculi. There was no staining in control sections exposed to the sense probes.
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Figure 7. Expression of EphA4 in the DR of El 5 rat brainstem. A) In situ
hybridization with the EphA4 antisense riboprobe, showing expression in the DR, as well as
in many celis in the surrounding regions, such as the superior colliculi (SC), and inferior
colliculi tIC). B) Area outlined in A, at bigher magnification. C and D) Adjacent section at
comparable magnifications, exposed to the control EphA4 sense riboprobe. AQ: aqueduct,
DR: dorsal raphe
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Figure 8. Expression of EphA5 in the DR of El 5 rat brainstem. A) In situ
hybridization with the EphA5 antisense probe, showing strong expression in the DR,
superior colliculi (SC), and inferior colliculi tIC). B) Higher magnification of area outlined
in A. C and D) Adjacent section at comparable magnifications, exposed to the control
EphA5 sense riboprobe.
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Figure 9. Expression of EphA7 in the DR 0f El 5 rat brainstem. A) In situ
hybridization with the EphA 7 antisense riboprobe. B) Uigher magnification of area outlined
in A. C and D) Adjacent section at comparable magnifications, exposed to the control
EphA 7 sense probe.
SC: superior colliculi, IC: inferior colliculi, AQ: aqueduct, DR: dorsal raphe
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3.3. Expression ofEphA5 in the DR of neonatal rat brain
We used anti-SERT immunohistochemistry to locate the 5-HT neurons ofthe dorsal
raphe in the neonatal brain, on sections adjacent to those used for in situ hybridization (fig.
1 OA, B). The in situ hybridization shows that EphA5 is stiil expressed in the DR at this
stage, as well as in adjacent brainstem regions, including the ventral tegmental area (VTA)
or central gray (CG) (fig. 1 OC-f). Technical difficulties made it impossible to obtain data
for the other two molecules in time for this thesis.
3.4. Expression of EphA4, EphAS and EphA 7 in the DR of aduit mouse brain
Anti-SERT immunohistochemistry was also used to locate the 5-HT neurons in the
DR ofthe aduit mouse in sections adjacent to those used for in situ hybridization (Fig.
1YA,B). Compared to embryonic (and neonatal, for EphA5) brain, the number oflabelled
ceils was markedly decreased in the aduit brainstem and DR. Nevertheless, EphA4, EphA5,
and EphA 7 were stili expressed in many ceils, in the DR as well as in other areas such as
the inferior colliculi and periaqueductal gray (Figs. 1 1C-f, 12, 13).
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Figure 10. Expression of EphA5 in the DR of P0 rat brainstem. A) In situ
hybridization with the EphA5 antisense riboprobe, showing expression in the DR and
surrounding regions. B) Area outlined in A, at higher magnification. C and D) Adjacent
section at comparable magnifications, exposed to ifie control EphA5 sense probe. LV: lateal
venricle, Cxp : cortical plate, PC : paracentral thalami nucleus.
SERT SERT
- DR
(A) (B)
Figure 11. Serotonin neurons in DR 0f aduit mouse. A) lmmunohistochemistry anti-
SERT to identify 5-UT neurons in DR. B) Mea outlined in A, at higher maginification.
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Figure 12. Expression of EphA4 in the DR of P60 aduit mouse brainstem. A) EphA4
antisense riboprobe, showing a relatively strong expression in the DR, as well as in some
ceils in the surrounding regions, sucli as peri aqueductal grey and cuneiform nucleus; B)
Area outlined in A, at higher magnification. C and D) Adjacent section at comparable
magnifications, exposed to the control EphA4 sense probe. IC: inferior colliculi, DR: dorsal
raphe, PAG: peri aqueductal grey maffer, CliN: cuneiform nucleus.
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Figure 13. Expression of EphA5 in the DR of P60 aduit mouse brainstem. A) EphA5
antisense riboprobe; B) Uigher magnification. C and D) Control EphA4 sense
riboprobe.SC: superior colliculi, IC: inferior colliculi.
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Figure 14. Expression of EphA7 in the DR region of P60 aduit mouse brainstem.
A) EphA 7 antisense probe; B) Higher magnification. C and D) Control EphA 7 sense
riboprobe. Abbreviations as above.
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3.5. Detection of ephrin-A4 and ephrin-A5 in membranes extracted from the Ctx, Str,
and VM
We used Western blotting to assess the presence of ephrin-A4 and ephrin-A5 in the
membranes extracted from the neonatal Ctx, Str, and VM, the 3 brain regions that had been
used to test the guidance of 5-HT axons in our laboratory (Petit et aï., 2005; SharifAskari,
2006). After the immunodetection of each ephrin, we performed a stripping of the blot
membranes to process with an anti-43—actin antibody in order to monitor the amount of
proteins in each lane. The immunoblots showed that ephrin-A4 was relatively abundant in
Ctx and VM membrane extracts, but somewhat less in Str membranes (fig. 15).
Ephrin-A5, was most abundant in VM, somewhat less in Ctx, and barely detectable in Str
membranes from neonatal rat brain (f ig.16).
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Ephrin-A4 57KD
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Figure.15. Ephrin-A4 expression in membranes extracted from target regions.
Upper une, Western blot with ephrin-A4 antibody on the membranes extracted from frontal
cortex (Ctx), striatum (Str), and ventral midbrain (VM). Whole brain lysate was used as a
positive control. In the lower lane, following stripping, Western blot for I3actin antibody
showing the amounts of protein in each lane.
Lysate Ctx VM Str
Ephrin-A5 r:p 55KD
3-actine
— _ — 37KD
Figure.16. Ephrin-A5 expression in membranes extracted from target regions.
Upper line, Western blot with anti-ephrin-A5 antibody on the membranes extracted from
Ctx, VM and Str; whole brain lysate serving as positive control. Boffom lane: anti-3-actin.
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4. Discussion:
The 5-HT neurons ofthe DR, project to several brain regions including the VM,
hypothalamus, thalamus, Str, hippocampus and Ctx (Moore et aï., 197$; van der Kooy &
Hattori, 1980; Fallon & Loughlin, 1982; 1mai et al., 1986). Our laboratory is aiming to
define the factors that guide S-HT axons to their target flelds in the forebrain and midbrain.
$ince recent in vitro experiments in our laboratory suggested that ephrin-As might be
involved in the branching of 5-HT axons on ceil membranes extracted from the Ctx, $tr or
VM, the aim of the present work was to investigate the presence of such molecules in these
brain regions, as well as the expression of some of their receptors, EphAs, in the DR.
EphAs and ephrin-As are expressed in several brain regions during development,
but their expression lias flot been examined in detail in the brainstem untili now.
4.1. EphA4, EphA5 and EphA7 are expressed in the DR at ail stages examined
We first used aduit mouse hippocampal sections as positive controls for our
riboprobes, since strong expression of EphA4, EphA5 and EphA7 had previously been
reported several times in this brain region of adult rodents (Gao et al., 1 99$b; Ciossek et
aï., 1999; Gerlai et al., 1999; Murai et al.. 2003). In the 3 cases, the distribution of the
labeling with the antisense riboprobes was consistent with the published observations,
while there was practically no staining with the control sense riboprobe; demonstrating the
specificity ofthe labeling.
The in situ hybridization showed clear expression of EphA4. EphA5 and EphA7 in
E15 rat brainstem, including the DR, as well as surrounding areas, like the superior and
inferior colliculi. It was, in fact, rather surprising to find such extensive expression of ail 3
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molecules in the brainstem, considering that these are presurned to be receptors to axon
guidance molecules. Nevertheless, this labeling pattern is consistent with the distributions
published in online databases ( jrainatIasor/ahajjy\\\gnepaintnrg). Since the 5-
HT innervation of forebrain and midbrain target regions deveiops perinatally, we tried to
investigate the expression of the Eph receptors at the time of birth, but succeeded only for
EphA5, for technical reasons that extended the deadiine for this thesis. Thus, in newborn
rat, the in situ hybridization for EphA5 also showed an extensive expression ofthis receptor
in the brainstem, including the DR. The DIG approach used here for in situ hybridization
did not allow detecting any eventual gradient of expression within the DR itself or among
other brainstem celis. The extensive distribution ofEphAs in brainstem in E15 and at birth
suggests that they have an important function during development. A number of in vivo and
in vitro studies that showed that ephrin-A gradients guide retinal ganglion celi axons to
their appropriate topographie locations in the superior colliculi (SC) and therefore EphAs
have a demonstrated role in the establishment of the retinotectal mapping and the axonai
guidance in visual pathways (Feldheim et al., 2000; Dufour et al., 2003; feldheim et al.,
2004). A more recent report showed that EphA4 also regulates the organization of auditory
pathways from the cochlea to the brainstem (Huffman & Cramer, 2007). Eph receptors and
ephrins have also been involved in the topographie guidance of other axonal projection
systems. including the nigrostriatal and mesolimbic dopamine (DA) pathways (Sieber et al.,
2004). But their role has not yet been investigated in 5-HT systems.
The functions of EphAs in the DR has not been invertigated yet. The extensive
expression of ail 3 receptors, EphA4, EphA5 and EphA7, in the fetal and neonatai
brainstem does not necessariiy fit with the presumed roles in axon guidance or neuronal
migration. To foilow up on these studies, it wiii be necessary to use a more quantitative
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technique for in situ hybridization, such as autoradiography, with radiolabelled riboprobes,
or fluorescence in situ hybridization. In this manner, it might be possible to detect
variations in the ievels of expression ofthese molecules among brainstem and DR neurons.
Gradients of expression would fit better with roles in axon guidance, in analogy with the
visual system.
However, the 3 receptors showed a more restricted expression in the aduit DR,
suggesting that these molecules may have more specific roles in aduit 5-HT, or other types
of DR neurons. As in the aduit hippocampus, they might be involved dendritic spine
maturation, synaptogenesis, or synaptic plasticity (Murai & Pasquale, 2004). It will be
important to use double-labeling experiments to positively demonstrate that the expression
of these molecules concems 5-HT neurons. At the moment, we can only presume that,
since the expression appeared to interest ail neurons in the DR, including large ceils similar
to 5-HT neurons, 5-HT neurons were indeed among the labeled ceils.
In summary, we were successful in developing riboprobes and in situ hybridization
protocols allowing to detect the expression of EphA4, EphA5 and EphA7 in fetal and
neonatal rat, as well as aduit mouse brain. Our preliminary observations show that the
expression of these molecules is extensive in the developing brainstem. It wlll thus be
necessary to refine the in situ hybridization approach to more finely characterize the
topographic expression of these molecules. It will also be useful to examine the expression
of these molecules in vitro, in 5-HT neurons that are challenged with membranes extracted
from target brain regions, as well as with membranes from celi unes expressing or flot any
oftheir ephrin-A iigands.
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4.2. Ephrin-A expression in Ctx, Str and VM of neonatal rat brain
We used Western blotting to detect the presence of ephrin-A4 and ephrin-A5 in the
ccli membranes extracted from the target regions of 5-HT innervations used in our
experimentations in vitro (neonatal Ctx, Str and VM). The specificity of the antibodies had
been tested in ceil unes expressing or flot these molecules (K. Murai, personal
communication). Both ephrin-A4 and ephrin-A5 were present in the membranes extracted
from the 3 target regions, but with a lower intensity in Str. This is consistent with previous
reports. Ephrin-A5 was reported to be expressed throughout the sensorimotor and auditory
cortices. Its mRNA was detectable first at low leveis at E16 and increased to peak intensity
during the late embryogenesis and early postnatal days (Gao et aï., 199$a; Yun et aï.,
2003). It was also shown that ephrin-A4 and ephrin-A5 mRNAs are present in the striatum,
in newbom rats, where they appear to take part in regulating the compartmental
organization of striatum (Janis et al., 1999). Littie is known about their fine distribution in
brainstem.
A finer description of the distribution of these ephrins would benefit from an
immunohistochemical approach. Unfortunately, antibodies convenient for
immunohistochemistry are difficuit to find. Our laboratory has tested several commercial
anti-ephrin-A2, anti-ephrin-A3 and anti-ephrin-A5 antibodies (including antibodies from
R&D, Zymed, or Santa Cruz) on brain sections from ephrin-A2, ephrin-A3, or ephrin-A5
knockout mice, respectively, which showed that these antibodies were flot suitable for
immunohistochemistry (although they were correct for Western blotting).
Nevertheiess, our current results demonstrate that at ieast some of the ephrin-As are
present in cdl membranes from the target brain regions innervated by DR 5-HT netirons.
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Together with the resuits ofthe in vitro experirnents by 3. Sharif Askari, these observations
are consistent with the hypothesis that ephrin-As and EphAs may serve as guidance cues
for 5-HT axons.
5. Conclusion
Ongoing experirnentation in our laboratory indicates a possible role for ephrins in
tEe guidance of 5-HT axons that project from DR to the Ctx, $tr or VM. Our present
preliminary resuits show that EphA4, EphA5 and EphA7 are expressed in the DR of
embryonic, neonatal and aduit rodents. The presence of ephrin-A4 and ephrin-A5 proteins
has also been demonstrated in ceil membranes extracted from the neonatal Ctx, Str and
VM. Together, these observations are consistent with the hypothesis of a role of these
molecules in the guidance of 5-HT axons to the selected regions. These preliminary results
need to be confirmed and reflned with more in vitro and in vivo experiments, notably to
better define the distribution of these molecules in the DR and its innervation target
domains. It wiii also be useful to define the eventual co-localization of several ephrin-As
and EphAs in the 5-HT neurons, since the guidance of their axons is most likely the resuit
of a combination of signais.
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